A5087617463- Liver Disease and Transplantation
- Liver Disease Diagnosis and Treatment
- Organ Transplantation Techniques and Outcomes
- RNA modifications and cancer
- Hepatocellular Carcinoma Treatment and Prognosis
- Hepatitis B Virus Studies
- Genomics and Phylogenetic Studies
- Viral gastroenteritis research and epidemiology
- Lung Cancer Research Studies
Southern Medical University
2022-2025
Nanfang Hospital
2022-2025
Dalian Medical University
2024
ABSTRACT Background & Aims Acute‐on‐chronic liver failure (ACLF) is a complex syndrome with limited treatment options. This study aims to investigate the impact of artificial support system (ALSS) on one‐year prognosis patients Hepatitis B virus (HBV)‐associated ACLF. Method A retrospective was conducted 239 HBV‐ACLF in Nanfang Hospital from January 2016 June 2021. Patients were divided into ALSS group ( n = 103) and Standard Medical Therapy (SMT group, 136). Demographic, clinical,...
Highlights•We validated the excellent performance of Baveno VII algorithm for ruling out HRV in those with HBV-related cirrhosis.•Compared VI, LSPS, PSR and RESIST, performed best avoiding unnecessary EGDs.•When applying cirrhosis, SSM@100 Hz probe better than SSM@50 Hz.AbstractBackground & AimsThe consensus recommends that spleen stiffness measurement (SSM) ≤40 kPa is safe high-risk varices (HRVs) endoscopic screening patients who do not meet VI criteria. This study aimed to validate...
Cirrhotic patients with liver stiffness measurement (LSM) <20kPa and platelet count ≥150/ul (Baveno VI criteria), otherwise spleen (SSM) ≤ 40kPa VI-SSM criteria) can avoid endoscopy screening, however, no prospective data for their hepatic outcomes. Compensated cirrhosis chronic hepatitis B were prospectively enrolled from April 2019 to 2022 followed until July 2023. All underwent LSM, SSM esophagogastroduodenoscopy (EGD) assessment. Among 1224 median follow-up of 30 months (IQR 21-42), the...
Summary Background Esophagogastroduodenoscopy (EGD) is required to screen for high‐risk varices (HRV) in patients with hepatocellular carcinoma (HCC), especially since overall survival rates have dramatically improved new systemic therapies. Aim To assess the Baveno VI and VII algorithms' ability rule out HRV hepatitis B virus (HBV)‐related HCC Methods We prospectively enrolled consecutive HBV related, compensated cirrhosis newly diagnosed who underwent liver stiffness measurement, spleen...
Introduction. Lung cancer ranks first among malignant tumors worldwide and is a leading cause of cancer-related mortality in both men women. Combining tumor marker testing strategy to screen individuals at high risk pulmonary minimize mortality. Therefore, screening crucial. In this study, we analyzed combinations markers for lung using receiver operating characteristic (ROC) curve analysis. Methods. A retrospective descriptive study was conducted on patients diagnosed with cancer, as well...